Verastem | VSTM - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
AbbVie USD 444.6B 59.91B 2026-06
Alaunos Therapeutics USD 7M 2M 2026-03
AstraZeneca USD 289.99B 11.26B 2026-06
Curis USD 22M 9M 2026-03
Cytokinetics USD 11.55B 3.36B 2026-06
Gilead Sciences USD 156.86B 16.13B 2026-06
Incyte USD 22.65B 3.92B 2026-06
Laboratory Of America USD 22.96B 1.03B 2026-06
Novartis USD 240.59B 67.17B 2026-06
Pfizer USD 138.44B 15.37B 2026-06
Roche Holding CHF 270B 3.66B 2026-06
TG Therapeutics USD 8.41B 3.1B 2026-06
Verastem USD 466M 130M 2026-03